Alkermes
ALKS
#2813
Rank
HK$45.05 B
Marketcap
HK$270.36
Share price
-0.98%
Change (1 day)
17.96%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): HK$2.37 Billion

According to Alkermes's latest financial reports the company's current earnings are HK$1.47 Billion. a decrease over its 2024 earnings that were of HK$3.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 HK$2.38 B-34.87%
2024 HK$3.65 B-17.97%
2023 HK$4.45 B-468.52%
2022 -HK$1.21 Billion449.24%
2021 -HK$0.23 Billion-68.04%
2020 -HK$0.69 Billion-52.1%
2019 -HK$1.44 Billion64.49%
2018 -HK$0.88 Billion-15.04%
2017 -HK$1.03 Billion-34.2%
2016 -HK$1.57 Billion-5.34%
2015 -HK$1.66 Billion35084.97%
2014 -HK$4.7 Million
2012 HK$58.16 M-117.81%
2011 -HK$0.33 Billion-12.69%
2010 -HK$0.38 Billion94.3%
2009 -HK$0.2 Billion-117.7%
2008 HK$1.08 B622.63%
2007 HK$0.15 B
2004 -HK$0.6 Billion-14.48%
2003 -HK$0.7 Billion11.88%
2002 -HK$0.63 Billion39.65%
2001 -HK$0.45 Billion5.73%
2000 -HK$0.43 Billion-28.91%
1999 -HK$0.6 Billion237.28%
1998 -HK$0.18 Billion100.05%
1997 -HK$87.86 Million-37.93%
1996 -HK$0.15 Billion82.72%
1995 -HK$77.46 Million-26.79%
1994 -HK$0.11 Billion-72.78%
1993 -HK$0.39 Billion208.07%
1992 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.92 B 10,946.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.14 B 5,283.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$79.86 B 3,255.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.33 B 2,434.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$73.09 B 2,971.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$110.55 B 4,544.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-HK$1.67 Billion-169.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-HK$2.13 Billion-189.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$16.86 B 608.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel